Historic Gene-Edited Pig Kidney Transplant Performed on Living Patient

In a groundbreaking medical achievement, a 62-year-old man becomes the first living recipient of a genetically modified pig kidney, marking a potential solution to organ shortages.

A 62-year-old man with end-stage renal disease received a genetically modified pig kidney in a successful surgery at Massachusetts General Hospital.
The pig kidney, engineered by eGenesis, underwent 69 genetic edits to improve compatibility and reduce rejection risks.
The patient, Richard Slayman, is recovering well and expected to be discharged soon, showcasing the procedure's initial success.
This milestone in xenotransplantation could address the critical shortage of human organs for transplantation, offering hope to thousands waiting for a kidney.
The FDA's compassionate use protocol allowed for this experimental treatment, highlighting the procedure's potential as a sustainable solution to organ shortages.